Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Leap Therapeutics
company
About
Leap Therapeutics is a clinical-stage biopharmaceutical company.
- 11 - 50
Highlights
Details
- Last Funding Type
- Post-IPO Equity
- Last Funding Money Raised
- $27M
- Industries
- Biotechnology,Life Science
- Founded date
- Jan 1, 2011
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Leap Therapeutics, Inc., a clinical-stage biopharmaceutical company, is engaged in acquiring and developing novel therapeutics. The company focus is to identify translational-stage molecules in the areas of cell signaling and immuno-oncology.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$27M
Leap Therapeutics has raised a total of
$27M
in funding over 2 rounds. Their latest funding was raised on
Jan 3, 2020 from a Post-IPO Equity round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 3, 2020 | Post-IPO Equity | $27M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Leap Therapeutics is funded by 1 investors.
BeiGene
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
BeiGene
|
— | Post-IPO Equity |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
